Company / Shareholders' Equity
LEXICON PHARMACEUTICALS, INC. Shareholders' Equity History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$107.5M
FY2025
5-year range
$93.1M / $167.5M
FY2021-FY2025
Trend
-26.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 10 years, ranging from $93M in FY2023 to $298M in FY2013.
Based on SEC 10-K filings.
$108M in FY2025 with a 10-year CAGR of -4.5%.
Improved from $93M to $108M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -4.5%
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 26.3% year-over-year.
- Peak shareholders' equity was recorded in FY2013.
- Lowest shareholders' equity in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $107.5M | -26.3% |
| FY2024 | $145.9M | +56.8% |
| FY2023 | $93.1M | -20.5% |
| FY2019 | $117.1M | -30.1% |
| FY2018 | $167.5M | -41.4% |
| FY2017 | $285.9M | +0.6% |
| FY2016 | $284.0M | +66.9% |
| FY2015 | $170.2M | -36.2% |
| FY2014 | $266.7M | -10.4% |
| FY2013 | $297.6M | +0.0% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026